Works matching IS 09291903 AND DT 2007 AND VI 14 AND IP 12

Results: 8

Radio-responsive TRAIL gene therapy for malignant gliomas.

Published in:

2007

By:

Kyritsis, A P;
Rao, J S;
Puduvalli, V K

Publication type:

Letter

An archaeal histone-like protein mediates efficient p53 gene transfer and facilitates its anti-cancer effect in vitro and in vivo.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 968, doi. 10.1038/sj.cgt.7701086

By:

Li, Y. Y.;
Wang, R.;
Zhang, G. L.;
Zheng, Y. J.;
Zhu, P.;
Zhang, Z. M.;
Fang, X. X.;
Feng, Y.

Publication type:

Article

The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411<sup>NTR</sup>.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 953, doi. 10.1038/sj.cgt.7701088

By:

Singleton, D. C.;
Li, D.;
Bai, S. Y.;
Syddall, S. P.;
Smaill, J. B.;
Shen, Y.;
Denny, W. A.;
Wilson, W. R.;
Patterson, A. V.

Publication type:

Article

DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 976, doi. 10.1038/sj.cgt.7701087

By:

Sanlioglu, A. D.;
Karacay, B.;
Koksal, I. T.;
Griffith, T. S.;
Sanlioglu, S.

Publication type:

Article

An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 985, doi. 10.1038/sj.cgt.7701089

By:

Griffith, C.;
Noonan, S.;
Lou, E.;
Shillitoe, E. J.

Publication type:

Article

The effects of knockdown of wild-type survivin, survivin-2B or survivin-Δ3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 994, doi. 10.1038/sj.cgt.7701090

By:

Kappler, M.;
Rot, S.;
Taubert, H.;
Greither, T.;
Bartel, F.;
Dellas, K.;
Hänsgen, G.;
Trott, K.-R.;
Bache, M.

Publication type:

Article

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 945, doi. 10.1038/sj.cgt.7701091

By:

Liu, C.-M.;
Yang, Z.;
Liu, C.-W.;
Wang, R.;
Tien, P.;
Dale, R.;
Sun, L.-Q.

Publication type:

Article

Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.

Published in:

Cancer Gene Therapy, 2007, v. 14, n. 12, p. 935, doi. 10.1038/sj.cgt.7701092

By:

Chen, C.-S.;
Jounaidi, Y.;
Su, T.;
Waxman, D. J.

Publication type:

Article